Hochschulschrift
Development of a highly potent bispecific antibody format targeting the novel tumor-specific antigen CLDN18.2
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Mainz, Univ., Diss., 2014
- Keyword
-
Krebs
Onkologie
- Event
-
Veröffentlichung
- (where)
-
Mainz
- (who)
-
Universitätsbibliothek Mainz
- (when)
-
2015
- Creator
- URN
-
urn:nbn:de:hebis:77-39449
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:57 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Holland, Julia
- Universitätsbibliothek Mainz
Time of origin
- 2015
Other Objects (12)
Restriction of hiv-1 escape by a highly broad and potent neutralizing antibody
Antigen antibody interactions
Restriction of HIV-1 escape by a novel highly broad and potent neutralizing antibody
Tumorantigen-Specific CD40B Cells: Combining Enhanced Antigen-Presentation and Antibody-Secretion for Tumor Targeting
Photoimmunotherapy of prostate cancer with antibody and Fab Fragments targeting the prostate specific membrane antigen
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Design and synthesis of highly potent and selective pseudokinase inhibitors targeting calcium/calmodulin-dependent serine protein kinase
Quality-targeting dynamic optimization of monoclonal antibody production
Monoclonal antibody targeting of ABCB5 in human malignant melanoma
Generation of an antibody targeting B cell maturation antigen for the treatment of multiple myeloma and autoimmune diseases
Establishing highly multiplexed microfluidic screening of protein-antibody interactions
Restriction of hiv-1 escape by a highly broad and potent neutralizing antibody
Antigen antibody interactions
Restriction of HIV-1 escape by a novel highly broad and potent neutralizing antibody
Tumorantigen-Specific CD40B Cells: Combining Enhanced Antigen-Presentation and Antibody-Secretion for Tumor Targeting
Photoimmunotherapy of prostate cancer with antibody and Fab Fragments targeting the prostate specific membrane antigen
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Design and synthesis of highly potent and selective pseudokinase inhibitors targeting calcium/calmodulin-dependent serine protein kinase
Quality-targeting dynamic optimization of monoclonal antibody production
Monoclonal antibody targeting of ABCB5 in human malignant melanoma
Generation of an antibody targeting B cell maturation antigen for the treatment of multiple myeloma and autoimmune diseases
Establishing highly multiplexed microfluidic screening of protein-antibody interactions
Restriction of hiv-1 escape by a highly broad and potent neutralizing antibody
Antigen antibody interactions
Restriction of HIV-1 escape by a novel highly broad and potent neutralizing antibody
Tumorantigen-Specific CD40B Cells: Combining Enhanced Antigen-Presentation and Antibody-Secretion for Tumor Targeting
Photoimmunotherapy of prostate cancer with antibody and Fab Fragments targeting the prostate specific membrane antigen
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Design and synthesis of highly potent and selective pseudokinase inhibitors targeting calcium/calmodulin-dependent serine protein kinase
Quality-targeting dynamic optimization of monoclonal antibody production
Monoclonal antibody targeting of ABCB5 in human malignant melanoma
Generation of an antibody targeting B cell maturation antigen for the treatment of multiple myeloma and autoimmune diseases